Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02914405 |
| Title | Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (MiniVan) |
| Acronym | MiniVan |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | University Hospital Southampton NHS Foundation Trust |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital | RECRUITING | Madison | Wisconsin | 53792 | United States | Details |
| University Hospital Southampton NHS Foundation Trust | RECRUITING | Southampton | Hampshire | SO16 6YD | United Kingdom | Details |
| University College London Hospital | RECRUITING | London | NW1 2BU | United Kingdom | Details |